The healthcare provider orders Benadryl 40 mg IM now. The available concentration is 25 mg/mL. How many mL will the patient receive?

Choice A reason: Dry cough is a common, not serious, side effect of ACE inhibitors due to bradykinin accumulation. While bothersome, it’s not life-threatening like angioedema. It often necessitates switching to an ARB, but calling it serious overstates the risk, making this choice incorrect.

Choice B reason: Dry cough occurs in 5-20% of ACE inhibitor users but doesn’t typically subside with continued use, as bradykinin accumulation persists. Patients often require a medication change (e.g., to ARBs), making the claim that it will subside over time inaccurate and incorrect.

Choice C reason: Dry cough is common but not universal in ACE inhibitor users, affecting 5-20% of patients due to variable bradykinin sensitivity. Stating it occurs in all patients is inaccurate, as many tolerate ACE inhibitors without cough, making this choice incorrect.

Choice D reason: Dry cough, caused by bradykinin buildup, affects some ACE inhibitor users and is uncomfortable, often requiring a switch to an ARB, which doesn’t affect bradykinin. This accurately reflects the side effect’s impact and management, making it the correct choice for the nurse’s response.

Choice A reason: Furosemide, a loop diuretic, promotes potassium excretion, risking hypokalemia. The patient’s potassium level (3.1 mEq/L) is below normal (3.5-5.0 mEq/L), indicating hypokalemia, which can cause arrhythmias. Administering Lasix without addressing this could worsen the electrolyte imbalance, making this choice unsafe and incorrect.

Choice B reason: Oxygen administration addresses respiratory issues, not electrolyte imbalances like hypokalemia (3.1 mEq/L) caused by furosemide. There’s no indication of hypoxia in the lab results or scenario. This action doesn’t correct the potassium deficit or prevent further depletion, making it irrelevant and incorrect.

Choice C reason: Furosemide exacerbates hypokalemia (patient’s potassium: 3.1 mEq/L), risking cardiac arrhythmias or muscle weakness. Holding the dose prevents further potassium loss, and notifying the physician allows for correction (e.g., potassium supplements) and reassessment of therapy, making this the safest and most appropriate action.

Choice D reason: A 24-hour urine collection assesses renal function or output but doesn’t address the immediate concern of hypokalemia (3.1 mEq/L) caused by furosemide. This test is irrelevant to correcting the electrolyte imbalance or preventing further depletion, making it an inappropriate action in this scenario.